Syrma SGS Technology Ltd Q1 FY27 Earnings Analysis

- Projected overall revenue growth of 30% to 35% supported by current orders and customer visibility. - Automotive segment grew 39% last year; expected to continue strong growth domestically and increased automotive exports. - Health care (MedTech) grew 36%; anticipated to cross INR 500 crores next year with sustained growth. - Industrial segment, including Elcome, grew 30%; new customers in power management and UPS sectors to drive growth. - Added 32 new customers last year, with 7 in the industrial segment across diverse applications like fuel injection, solar trackers, and FMCG liquid processing. - Export growth of around 25% to 30% expected, targeting INR 1,500+ crores next year. - Entry into PCB manufacturing planned in FY '27-'28, expected to add incremental revenue and accelerate growth beyond 30%-35%. - ODM business to sustain growth around 17%, contributing to overall margin improvement.

- Syrma SGS projects revenue growth of 30%-35% annually backed by strong order book and customer visibility. - Automotive segment grew 39%, healthcare 36%, industrial 30% (excluding Elcome slightly lower), with new customers in power management and UPS sectors supporting growth. - Exports grew 41% and targeted INR1,500+ crores in FY27, reflecting strong global market participation. - EBITDA margin guidance is conservative at 10.5%-11% for FY27 due to global uncertainties, despite delivering ~12% margins in FY26. - Operating EBITDA is expected to increase by about 30% in absolute terms. - MedTech turnover expected to cross INR500 crores next year. - Entry into PCB manufacturing business in FY27-28 is expected to provide incremental growth above the 30%-35% organic growth rate. - Focus on sustainable, quality growth with improved wallet share and operational efficiencies contributing to earnings growth.

- PCB Business Capex: Total INR800 crores planned for flexible PCB and copper clad laminates, spread over FY '28 to FY '30. - Phase 1: INR400 crores (INR50 crores spent till last year; INR250 crores expected this year; INR100 crores next year). - Phase 2: Planned over next year and mid FY '29. - Additional Organic Capex: INR100-150 crores expected annually. - Greenfield Project in Renewable Energy: Evaluating technology partners for inverter business; no firm plans yet but focus on entry into renewable space. - Funding: Capex partly funded through internal accruals, debt, and 25% contribution from JV partner for PCB. - Subsidies: Expected 50%-60% subsidy reimbursement on capex next year onward. - No expense impact from dropped Ksolare acquisition; expense charged off to P&L.

- For the PCB business capex, estimated at around INR800-1,400 crores over FY '28 to FY '30, funding will be partly through debt, partly internal accruals, and a 25% contribution from the JV partner. - For FY '27, PCB business capex is expected to be around INR250 crores, funded partly through debt and internal accruals. - The company currently holds a net cash position of INR470 crores and cash on hand of about INR829 crores, confident this is sufficient to fund growth and capex without cash shortages. - No explicit mention of fresh equity fundraising. - The company plans to manage capex and cash flows carefully, balancing debt and accruals to avoid cash flow challenges. - No new large debt/equity fundraising announced beyond these funding plans for growth and capex projects.

- As of March-end FY '26, the total order book stands at approximately INR6,600 crores with a recent net addition of about INR200 crores after Q4 delivery. - Order book growth has moderated to ~3% from a historical run rate of 7-10%, attributed to higher revenue execution rather than slowdown. - Order book mix: Automotive ~29%, Consumer ~30%, Industrial ~24%, Health Care ~5%, IT and Railways ~11%. - Elcome's order book is about 5% of total. - Orders generally vary in tenure; many customers provide shorter-term orders (3-12 months). - The company expects order book to be continuously updated with new orders in coming quarters to support projected 30-35% revenue growth for FY '27. - Current order book reflects existing business; pipeline growth expected to pick up and contribute to revenue beyond order book numbers.